Understanding how low oxygen levels worsen brain blood vessel malformations
Mechanisms of hypoxia induced exacerbation of cerebral cavernous malformations
This study is looking at how low oxygen levels in the brain can make abnormal blood vessel formations, called cerebral cavernous malformations (CCMs), worse, and it aims to find new ways to help people with CCMs by understanding the role of certain brain cells in this process.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10983778 on NIH RePORTER |
What this research studies
This research investigates how low oxygen conditions, known as hypoxia, can worsen cerebral cavernous malformations (CCMs), which are abnormal blood vessel formations in the brain. The study will explore the biological mechanisms involved, particularly focusing on the role of specific cells called astrocytes and the signaling pathways they activate under hypoxic conditions. By using animal models and human tissue samples, researchers aim to uncover how these factors contribute to the severity of CCMs and the risk of hemorrhagic strokes. The ultimate goal is to identify potential therapeutic targets that could lead to effective treatments for patients affected by CCMs.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with cerebral cavernous malformations, particularly those experiencing symptoms or complications related to the condition.
Not a fit: Patients without cerebral cavernous malformations or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce the risk of strokes and neurological deficits in patients with cerebral cavernous malformations.
How similar studies have performed: Previous research has indicated that targeting hypoxia-related pathways may be beneficial in other vascular disorders, suggesting potential for success in this novel approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Lopez-Ramirez, Miguel Alejandro — University of California, San Diego
- Study coordinator: Lopez-Ramirez, Miguel Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.